Motilal Oswal Private Equity (MOPE) and Rosewood Investments, the private equity arm of The Rosewood Corporation, have bought out private equity major Actis’ 70 per cent holding in Symbiotec Pharmalab Pvt Ltd, according to an announcement on Tuesday.
End the Year with a Deal You Can’t Miss!
Subscribe now and save 40% on our premium subscription.
Enjoy unlimited access for a full year at just $199 (usual price $339).
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Offer valid for a limited time – don’t wait to unlock the insights that drive deal-making in Asia!
Subscribe nowAlready a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com